Patents by Inventor Minggui Lin

Minggui Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250034080
    Abstract: A novel type of cationic lipid and PEGylated derivative thereof, a cationic liposome and a cationic liposome-nucleic acid pharmaceutical composition containing the cationic lipid and formulation thereof include an ionizable lipid compound of the general formula (1). This compound is slightly ionized or neutral at physiological pH but undergoes greater ionization under acidic conditions, exhibiting lower toxicity in the systemic circulation and improved endosomal escape ability. The compound's polar head contains an ionizable tertiary amine group along with a side chain containing functional groups, while the tail chains may include linking groups that are easily degraded. Cationic liposomes containing the compound have a better ability to complex with nucleic acid drugs, higher stability in serum, no apparent cytotoxicity, and high transfection efficiency.
    Type: Application
    Filed: January 1, 2023
    Publication date: January 30, 2025
    Applicant: XIAMEN SINOPEG BIOTECH CO., LTD.
    Inventors: Sheng LIN, Minggui LIN, Dandan CHEN, Ailan WANG, Congming LIN, Qi ZHU, Wengui WENG, Chao LIU, Jinchun YUAN
  • Publication number: 20240335384
    Abstract: A novel cationic lipid having a structure as represented by general formula (1), which specifically relates to a nitrogen-containing cationic lipid, and also relates to a liposome containing the cationic lipid, a liposome pharmaceutical composition containing said cationic lipid, preparation and application thereof. A cationic liposome containing the cationic lipid represented by formula (1), can improve the loading rate and transport rate of drugs, particularly nucleic acid drugs. The terminus of the novel cationic lipid can contain a fluorescent group or a targeting group, so that the cationic liposome pharmaceutical composition containing the cationic lipid can have fluorescent or targeting function.
    Type: Application
    Filed: October 13, 2022
    Publication date: October 10, 2024
    Applicant: XIAMEN SINOPEG BIOTECH CO., LTD.
    Inventors: Sheng LIN, Minggui LIN, Ailan WANG, Linlin WANG, Wengui WENG, Chao LIU, Jinchun YUAN, Qian LIN
  • Publication number: 20240197633
    Abstract: A novel PEGylated lipid and preparation methods thereof, a cationic liposome containing the PEGylated lipid, a pharmaceutical composition containing the liposome, a formulation and application thereof. The PEGylated lipid can be used for modifying a liposome, and it can be further modified and coupled with a targeting group, and then used for modifying a liposome to obtain a liposome with the targeting group. Due to the presence of a long-chain PEG and the targeting group on the lipid, the modified liposome can avoid being removed by the reticuloendothelial system in a human body and realize a targeting function. Therefore, when the modified liposome delivers an active drug to cells or a patient, especially when delivering a nucleic acid or anti-tumor drug, the liposome can realize long circulation in vivo and improve the transport efficiency of drug, and has a targeting unction so the therapeutic effect of a drug is improved.
    Type: Application
    Filed: April 7, 2022
    Publication date: June 20, 2024
    Applicant: XIAMEN SINOPEG BIOTECH CO., LTD.
    Inventors: Wengui WENG, Chao LIU, Ailan WANG, Minggui LIN, Qiaoyan LIU
  • Patent number: 11522734
    Abstract: The present invention provides a method for controlling a remote service access path including the steps of: receiving a datagram sent by any terminal intending to access the remote service; requesting a node management server to determine an optimal gateway server as an optimal node for transferring the datagram, the optimal gateway server being selected from a number of gateway servers provided for a distributed deployment architecture established for a server cluster of the remote service; testing transmission quality of a number of accessed data connections to the optimal gateway server, and determining an optimal data connection having optimal transmission quality; and invoking the optimal data connection to send a datagram after tunnel encapsulation thereof, and the optimal gateway server forwarding the datagram to a business server connected to the optimal gateway server and belonging to the server cluster.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: December 6, 2022
    Assignee: GUANGZHOU HUADUO NETWORK TECHNOLOGY CO., LTD.
    Inventors: Minggui Lin, Tao Zhang, Zhengxian Lin, Xun Feng, Shunwen Tan
  • Publication number: 20190342117
    Abstract: The present invention provides a method for controlling a remote service access path including the steps of: receiving a datagram sent by any terminal intending to access the remote service; requesting a node management server to determine an optimal gateway server as an optimal node for transferring the datagram, the optimal gateway server being selected from a number of gateway servers provided for a distributed deployment architecture established for a server cluster of the remote service; testing transmission quality of a number of accessed data connections to the optimal gateway server, and determining an optimal data connection having optimal transmission quality; and invoking the optimal data connection to send a datagram after tunnel encapsulation thereof, and the optimal gateway server forwarding the datagram to a business server connected to the optimal gateway server and belonging to the server cluster.
    Type: Application
    Filed: July 19, 2019
    Publication date: November 7, 2019
    Inventors: Minggui Lin, Tao Zhang, Zhengxian Lin, Xun Feng, Shunwen Tan